Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Laxido Orange oral powder sachets
0106040M0BCAAAE
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 59 |
|
Strigol oral powder 13.72g sachets orange
0106040M0BLABAA
|
Strigol | Macrogol 3350 | Gastro-Intestinal System | 23 |
|
Laxido Natural oral powder 13.7g sachets
0106040M0BCABAA
|
Laxido | Macrogol 3350 | Gastro-Intestinal System | 4 |
|
Macroherm oral powder 13.8g sachets
0106040M0BFABAE
|
Macroherm | Macrogol 3350 | Gastro-Intestinal System | 2 |
|
Molative oral powder 13.8g sachets
0106040M0BIAAAA
|
Molative | Macrogol 3350 | Gastro-Intestinal System | 1 |
|
Strigol Paediatric oral powder 6.86g sachets
0106040M0BLACAB
|
Strigol | Macrogol 3350 | Gastro-Intestinal System | 1 |
|
Laxagol oral powder sachets
0106040M0BEAAAA
|
Laxagol | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Macilax oral powder 13.8g sachets
0106040M0BHAAAA
|
Macilax | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Macilax Paediatric oral powder 6.9g sachets
0106040M0BHABAB
|
Macilax | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Molative Paediatric oral powder 6.9g sachets
0106040M0BIABAB
|
Molative | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
VistaPrep oral powder 110g sachets
0106040M0BKAAAA
|
VistaPrep | Macrogol 3350 | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.